Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that suitable stockpiles of essential medications are available to the NHS to limit the effects of production shortages.

Whilst stock of a small number of medicines is held by the Government, for example as a result of COVID-19 preparedness, stockpiling essential medicines centrally is not a tool that the Department uses to limit the effects of production shortages. While we can’t always prevent supply issues from occurring, we have a range of well-established processes and tools to manage them when they do arise, to mitigate risks to patients. These include close and regular engagement with suppliers, use of alternative strengths or forms of a medicine to allow patients to remain on the same product, expediting regulatory procedures, sourcing unlicensed imports from abroad, adding products to the restricted exports and hoarding list, use of Serious Shortage Protocols, and issuing National Health Service communications to provide management advice and information on the issue to healthcare professionals, including pharmacists, so they can advise and support their patients.